The goal of genome editing technology is to develop strategies for the correction of those mutations that are responsible of ...

Racehorses in Britain are to be tested for gene doping as part of a new initiative by the British Horseracing Authority.

AccurEdit Therapeutics today announced that its innovative in vivo gene editing product, ART001, has obtained Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA).

Verve received FDA IND clearance for VERVE-102 to treat HeFH, adding new trial sites in the United States. Read more about ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

LONDON - Racehorses in Britain will be tested for gene doping after the British Horseracing Authority (BHA) spent nearly two ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

The British Horseracing Authority (BHA) is expanding its world-leading equine Anti-Doping programme to include testing for ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

Racehorses to be tested for gene doping as new initiative announced ahead of Grand National - A new initiative has been ...

As unbelievable as it may seem, woolly mammoths are potentially returning to our planet. According to an article from The ...